A more safe immunoglobulin preparation, especially one used for intramuscular injection, that can be obtained by an efficient and well-operable production process without causing viral contamination. The preparation is HCV genome negative, contains HCV genome in a concentration of at most 1 PCR unit/ml in a 0.1-15 w/v % immunoglobulin solution, and has a HCV genome removal rate of 10<3> or above.
申请公布号
WO9609839(A1)
申请公布日期
1996.04.04
申请号
WO1995JP01979
申请日期
1995.09.28
申请人
THE GREEN CROSS CORPORATION;TAKAHASHI, TUYOSHI;MIYANO, KENMI;NISHIMAKI, HIDEO;IRIE, KOICHI;SAKI, TOSHIYUKI;TOMIOKA, SHINJI